Stan Deresinski, MD, FACP, FIDSA

Director, Stanford Antimicrobial Sustainability and Safety Program
Stanford Health Care

Disclosure(s): No financial relationships to disclose

Poster(s):

• 1863 - Treatment and Outcomes of Cefoxitin-Non-Susceptible Serratia marcescens, Klebsiella aerogenes, Citrobacter freundii, Enterobacter cloacae, and Morganella morganii Bacteremia with Piperacillin/Tazobactam Versus Cefepime or Carbapenem in Immunocompromised Patients
  Saturday, October 22, 2022

  12:15 PM – 1:30 PM US ET